Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus
NCT02508220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2015-12-02
Summary
The study compares the short-term tinnitus reduction following a single oxytocin intervention with a placebo control condition.
Conditions
- Chronic Tinnitus
Interventions
- DRUG
-
Syntocinon
Oxytocin nasal spray
- DRUG
-
distilled water in nasal spray
Sponsors & Collaborators
-
Otosul -Otorrinolaringologia Sul-Fluminense
collaborator UNKNOWN -
Berthold Langguth, MD, Ph.D.
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
More Related Trials
-
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
TNF-α Treatment of Blast-Induced Tinnitus
NCT04066348 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
NCT02315508 ·Status: COMPLETED ·Phase: PHASE2
-
Antioxidation Medication for Noise-induced Hearing Loss
NCT00552786 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT00955799 ·Status: COMPLETED ·Phase: PHASE3
-
Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity
NCT01108601 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus
NCT03336398 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT00739635 ·Status: COMPLETED ·Phase: PHASE3
-
Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus
NCT02737670 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of Wuling Capsule in Treatment Chronic Tinnitus
NCT03674853 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
NCT00772980 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
NCT06025097 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neramexane for Tinnitus
NCT00405886 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
NCT02038972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of BGG492 in Patients With Chronic Subjective Tinnitus
NCT01302873 ·Status: COMPLETED ·Phase: PHASE2
-
Stress Management Therapy for Meniere's Disease
NCT01099046 ·Status: UNKNOWN ·Phase: NA
-
Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
NCT00279916 ·Status: COMPLETED ·Phase: PHASE3
-
Performance and Safety of Otinova® Ear Spray
NCT05370209 ·Status: TERMINATED ·Phase: NA
-
Commercial Lidocaine Patch as a Treatment for Ear-ringing
NCT02088866 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT05328895 ·Status: COMPLETED ·Phase: NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
NCT04686695 ·Status: COMPLETED ·Phase: NA
-
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
NCT00827008 ·Status: TERMINATED ·Phase: PHASE3
-
The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
NCT05650645 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
NCT07254442 ·Status: COMPLETED